143 related articles for article (PubMed ID: 31625572)
1. AKT signaling promotes DNA damage accumulation and proliferation in polycystic kidney disease.
Conduit SE; Davies EM; Ooms LM; Gurung R; McGrath MJ; Hakim S; Cottle DL; Smyth IM; Dyson JM; Mitchell CA
Hum Mol Genet; 2020 Jan; 29(1):31-48. PubMed ID: 31625572
[TBL] [Abstract][Full Text] [Related]
2. Inpp5e suppresses polycystic kidney disease via inhibition of PI3K/Akt-dependent mTORC1 signaling.
Hakim S; Dyson JM; Feeney SJ; Davies EM; Sriratana A; Koenig MN; Plotnikova OV; Smyth IM; Ricardo SD; Hobbs RM; Mitchell CA
Hum Mol Genet; 2016 Jun; 25(11):2295-2313. PubMed ID: 27056978
[TBL] [Abstract][Full Text] [Related]
3. β-catenin ablation exacerbates polycystic kidney disease progression.
Conduit SE; Hakim S; Feeney SJ; Ooms LM; Dyson JM; Abud HE; Mitchell CA
Hum Mol Genet; 2019 Jan; 28(2):230-244. PubMed ID: 30265301
[TBL] [Abstract][Full Text] [Related]
4. Extracellular Glutamate-Induced mTORC1 Activation via the IR/IRS/PI3K/Akt Pathway Enhances the Expansion of Porcine Intestinal Stem Cells.
Zhu M; Qin YC; Gao CQ; Yan HC; Li XG; Wang XQ
J Agric Food Chem; 2019 Aug; 67(34):9510-9521. PubMed ID: 31382738
[TBL] [Abstract][Full Text] [Related]
5. Are Wnt/β-Catenin and PI3K/AKT/mTORC1 Distinct Pathways in Colorectal Cancer?
Prossomariti A; Piazzi G; Alquati C; Ricciardiello L
Cell Mol Gastroenterol Hepatol; 2020; 10(3):491-506. PubMed ID: 32334125
[TBL] [Abstract][Full Text] [Related]
6. Discrete signaling mechanisms of mTORC1 and mTORC2: Connected yet apart in cellular and molecular aspects.
Jhanwar-Uniyal M; Amin AG; Cooper JB; Das K; Schmidt MH; Murali R
Adv Biol Regul; 2017 May; 64():39-48. PubMed ID: 28189457
[TBL] [Abstract][Full Text] [Related]
7. A study of sirolimus and mTOR kinase inhibitor in a hypomorphic
Holditch SJ; Brown CN; Atwood DJ; Lombardi AM; Nguyen KN; Toll HW; Hopp K; Edelstein CL
Am J Physiol Renal Physiol; 2019 Jul; 317(1):F187-F196. PubMed ID: 31042058
[TBL] [Abstract][Full Text] [Related]
8. The PI3K/Akt/mTOR pathway in polycystic kidney disease: A complex interaction with polycystins and primary cilium.
Margaria JP; Campa CC; De Santis MC; Hirsch E; Franco I
Cell Signal; 2020 Feb; 66():109468. PubMed ID: 31715259
[TBL] [Abstract][Full Text] [Related]
9. Deletion of Aurora kinase A prevents the development of polycystic kidney disease in mice.
Tham MS; Cottle DL; Zylberberg AK; Short KM; Jones LK; Chan P; Conduit SE; Dyson JM; Mitchell CA; Smyth IM
Nat Commun; 2024 Jan; 15(1):371. PubMed ID: 38191531
[TBL] [Abstract][Full Text] [Related]
10. Integrin-Linked Kinase Signaling Promotes Cyst Growth and Fibrosis in Polycystic Kidney Disease.
Raman A; Reif GA; Dai Y; Khanna A; Li X; Astleford L; Parnell SC; Calvet JP; Wallace DP
J Am Soc Nephrol; 2017 Sep; 28(9):2708-2719. PubMed ID: 28522687
[TBL] [Abstract][Full Text] [Related]
11. Phosphorylation of DEPDC5, a component of the GATOR1 complex, releases inhibition of mTORC1 and promotes tumor growth.
Padi SKR; Singh N; Bearss JJ; Olive V; Song JH; Cardó-Vila M; Kraft AS; Okumura K
Proc Natl Acad Sci U S A; 2019 Oct; 116(41):20505-20510. PubMed ID: 31548394
[TBL] [Abstract][Full Text] [Related]
12. Diverse signaling mechanisms of mTOR complexes: mTORC1 and mTORC2 in forming a formidable relationship.
Jhanwar-Uniyal M; Wainwright JV; Mohan AL; Tobias ME; Murali R; Gandhi CD; Schmidt MH
Adv Biol Regul; 2019 May; 72():51-62. PubMed ID: 31010692
[TBL] [Abstract][Full Text] [Related]
13. Loss of Tsc1, but not Pten, in renal tubular cells causes polycystic kidney disease by activating mTORC1.
Zhou J; Brugarolas J; Parada LF
Hum Mol Genet; 2009 Nov; 18(22):4428-41. PubMed ID: 19692352
[TBL] [Abstract][Full Text] [Related]
14. A functional genetic screen defines the AKT-induced senescence signaling network.
Chan KT; Blake S; Zhu H; Kang J; Trigos AS; Madhamshettiwar PB; Diesch J; Paavolainen L; Horvath P; Hannan RD; George AJ; Sanij E; Hannan KM; Simpson KJ; Pearson RB
Cell Death Differ; 2020 Feb; 27(2):725-741. PubMed ID: 31285545
[TBL] [Abstract][Full Text] [Related]
15. Overexpression of exogenous kidney-specific Ngal attenuates progressive cyst development and prolongs lifespan in a murine model of polycystic kidney disease.
Wang E; Chiou YY; Jeng WY; Lin HK; Lin HH; Chin HJ; Leo Wang CK; Yu SS; Tsai SC; Chiang CY; Cheng PH; Lin HJ; Jiang ST; Chiu ST; Hsieh-Li HM
Kidney Int; 2017 Feb; 91(2):412-422. PubMed ID: 28341240
[TBL] [Abstract][Full Text] [Related]
16. Effects of PEP-1-FK506BP on cyst formation in polycystic kidney disease.
Jo HS; Eum WS; Park EY; Ko JY; Kim DY; Kim DW; Shin MJ; Son O; Cho SB; Park JH; Lee CH; Yeo EJ; Yeo HJ; Choi YJ; Youn JK; Cho SW; Park J; Park JH; Choi SY
BMB Rep; 2017 Sep; 50(9):460-465. PubMed ID: 28760196
[TBL] [Abstract][Full Text] [Related]
17. A positive feedback loop involving EGFR/Akt/mTORC1 and IKK/NF-kB regulates head and neck squamous cell carcinoma proliferation.
Li Z; Yang Z; Passaniti A; Lapidus RG; Liu X; Cullen KJ; Dan HC
Oncotarget; 2016 May; 7(22):31892-906. PubMed ID: 26895469
[TBL] [Abstract][Full Text] [Related]
18. Constitutive activation of the PI3K-Akt-mTORC1 pathway sustains the m.3243 A > G mtDNA mutation.
Chung CY; Singh K; Kotiadis VN; Valdebenito GE; Ahn JH; Topley E; Tan J; Andrews WD; Bilanges B; Pitceathly RDS; Szabadkai G; Yuneva M; Duchen MR
Nat Commun; 2021 Nov; 12(1):6409. PubMed ID: 34737295
[TBL] [Abstract][Full Text] [Related]
19. Bi-steric mTORC1 inhibitors induce apoptotic cell death in tumor models with hyperactivated mTORC1.
Du H; Yang YC; Liu HJ; Yuan M; Asara JM; Wong KK; Henske EP; Singh M; Kwiatkowski DJ
J Clin Invest; 2023 Nov; 133(21):. PubMed ID: 37909334
[TBL] [Abstract][Full Text] [Related]
20. Dual Targeting of Akt and mTORC1 Impairs Repair of DNA Double-Strand Breaks and Increases Radiation Sensitivity of Human Tumor Cells.
Holler M; Grottke A; Mueck K; Manes J; Jücker M; Rodemann HP; Toulany M
PLoS One; 2016; 11(5):e0154745. PubMed ID: 27137757
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
